StoxGud Sign in

Max Healthcare Institute vs Fortis Healthcare: share price & financials comparison

NSE: MAXHEALTH vs FORTIS · Healthcare · as of 13 Nov 2026

Max Healthcare InstituteNSE: MAXHEALTH₹947.10 +0.08%Neutral setup · 4/10vsFortis HealthcareNSE: FORTIS₹764.00 +0.53%Neutral setup · 4/10

Both prices rebased to 100 at the start of the selected period.

Max Healthcare Institute vs Fortis Healthcare at a glance

Max Healthcare Institute (MAXHEALTH) has a market capitalisation of ₹92,182 Cr, against ₹57,679 Cr for Fortis Healthcare (FORTIS). Over the past year Max Healthcare Institute has returned -16.8%, compared with -25.0% for Fortis Healthcare. On valuation, Fortis Healthcare trades at a lower P/E of 55.5 versus 66.7. Max Healthcare Institute earns a higher return on equity (12.2% vs 9.9%). Max Healthcare Institute comes out ahead on size, profitability, growth, momentum and technicals. Fortis Healthcare comes out ahead on valuation and financial health. Across the scored metrics below, Max Healthcare Institute leads on 11 and Fortis Healthcare on 6. On StoxGud's 10-point checklist, Max Healthcare Institute scores 4/10 and Fortis Healthcare scores 4/10.

MetricMax Healthcare InstituteFortis Healthcare
Size
Market cap₹92,182 Cr₹57,679 Cr
Revenue (latest FY)₹8,373 Cr₹9,128 Cr
Net profit (latest FY)₹1,442 Cr₹1,042 Cr
Valuation
P/E66.755.5
P/B8.135.50
Dividend yield0.16%0.13%
Profitability
Return on equity12.2%9.9%
Net profit margin15.1%10.5%
Operating margin26.8%22.2%
Growth
Revenue growth (YoY)+20.3%+17.3%
Net profit growth (YoY)-15.5%-3.0%
Revenue CAGR (multi-year)+27.3%+17.8%
Financial health
Debt to equity0.330.30
Momentum
1-month return+10.0%+1.0%
1-year return-16.8%-25.0%
3-year CAGR+16.9%+27.5%
5-year CAGR+21.1%+22.6%
10-year CAGR—+16.8%
Distance from 52W high-19.8%-25.1%
Technicals
RSI (14)8962
Price vs 200-day avg-6.2%-14.2%

Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.

10-point checklist side by side

CheckMax Healthcare InstituteFortis Healthcare
Price above 50-day average✓✗
Price above 200-day average✗✗
50-day average above 200-day (uptrend)✗✗
RSI in healthy 40–70 zone✗✓
Positive 1-year return✗✗
Return on equity above 15%✗✗
Debt to equity below 1✓✓
Revenue growing year on year✓✓
Net profit margin above 10%✓✓
P/E below industry median✗✗
Score4/104/10

A rules-based screen for education only — not a buy or sell recommendation.

FAQs

Which is bigger, Max Healthcare Institute or Fortis Healthcare?

Max Healthcare Institute has a market cap of ₹92,182 Cr and Fortis Healthcare has a market cap of ₹57,679 Cr as of 13 Nov 2026.

Which has a lower P/E, Max Healthcare Institute or Fortis Healthcare?

Fortis Healthcare has the lower P/E: Max Healthcare Institute trades at 66.7 and Fortis Healthcare at 55.5.

Which gave better returns in the last year, Max Healthcare Institute or Fortis Healthcare?

Max Healthcare Institute did better: Max Healthcare Institute returned -16.8% and Fortis Healthcare returned -25.0% over one year.

What is the difference between Max Healthcare Institute and Fortis Healthcare?

Both are NSE-listed companies in Healthcare. Max Healthcare Institute is about 1.6 times the size of Fortis Healthcare by market cap. In the latest financial year Max Healthcare Institute reported revenue of ₹8,373 Cr and Fortis Healthcare ₹9,128 Cr. Operating margin is 26.8% for Max Healthcare Institute and 22.2% for Fortis Healthcare. Debt to equity is 0.33 for Max Healthcare Institute and 0.30 for Fortis Healthcare.

Which is better, Max Healthcare Institute or Fortis Healthcare?

It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Max Healthcare Institute leads on 11 and Fortis Healthcare on 6. Max Healthcare Institute is ahead on size, profitability, growth, momentum and technicals. Fortis Healthcare is ahead on valuation and financial health. On StoxGud's rules-based checklist Max Healthcare Institute scores 4/10 and Fortis Healthcare scores 4/10. This is information, not advice: consult a SEBI-registered adviser before investing.

More comparisons